BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19513529)

  • 1. Epigallocatechin-3-gallate improves nonalcoholic steatohepatitis model mice expressing nuclear sterol regulatory element binding protein-1c in adipose tissue.
    Ueno T; Torimura T; Nakamura T; Sivakumar R; Nakayama H; Otabe S; Yuan X; Yamada K; Hashimoto O; Inoue K; Koga H; Sata M
    Int J Mol Med; 2009 Jul; 24(1):17-22. PubMed ID: 19513529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic mice expressing nuclear sterol regulatory element-binding protein 1c in adipose tissue exhibit liver histology similar to nonalcoholic steatohepatitis.
    Nakayama H; Otabe S; Ueno T; Hirota N; Yuan X; Fukutani T; Hashinaga T; Wada N; Yamada K
    Metabolism; 2007 Apr; 56(4):470-5. PubMed ID: 17379003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of adiponectin transgenic expression in liver of nonalcoholic steatohepatitis model mice.
    Nakayama H; Otabe S; Yuan X; Ueno T; Hirota N; Fukutani T; Wada N; Hashinaga T; Yamada K
    Metabolism; 2009 Jul; 58(7):901-8. PubMed ID: 19394977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary (-)-Epigallocatechin-3-gallate Supplementation Counteracts Aging-Associated Skeletal Muscle Insulin Resistance and Fatty Liver in Senescence-Accelerated Mouse.
    Liu HW; Chan YC; Wang MF; Wei CC; Chang SJ
    J Agric Food Chem; 2015 Sep; 63(38):8407-17. PubMed ID: 26152236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet.
    Muraoka T; Aoki K; Iwasaki T; Shinoda K; Nakamura A; Aburatani H; Mori S; Tokuyama K; Kubota N; Kadowaki T; Terauchi Y
    Metabolism; 2011 May; 60(5):617-28. PubMed ID: 20673929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pivotal Role of TNF-α in the Development and Progression of Nonalcoholic Fatty Liver Disease in a Murine Model.
    Kakino S; Ohki T; Nakayama H; Yuan X; Otabe S; Hashinaga T; Wada N; Kurita Y; Tanaka K; Hara K; Soejima E; Tajiri Y; Yamada K
    Horm Metab Res; 2018 Jan; 50(1):80-87. PubMed ID: 28922680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigallocatechin gallate attenuates experimental non-alcoholic steatohepatitis induced by high fat diet.
    Kuzu N; Bahcecioglu IH; Dagli AF; Ozercan IH; Ustündag B; Sahin K
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e465-70. PubMed ID: 17683497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decaffeinated green tea extract rich in epigallocatechin-3-gallate prevents fatty liver disease by increased activities of mitochondrial respiratory chain complexes in diet-induced obesity mice.
    Santamarina AB; Carvalho-Silva M; Gomes LM; Okuda MH; Santana AA; Streck EL; Seelaender M; do Nascimento CM; Ribeiro EB; Lira FS; Oyama LM
    J Nutr Biochem; 2015 Nov; 26(11):1348-56. PubMed ID: 26300331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
    J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice.
    Lee MS; Kim CT; Kim Y
    Ann Nutr Metab; 2009; 54(2):151-7. PubMed ID: 19390166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin suppresses endoplasmic reticulum stress in nonalcoholic steatohepatitis.
    Ueno T; Nakamura A; Nakayama H; Otabe S; Yuan X; Fukutani T; Iwamoto H; Nakamura T; Koga H; Torimura T; Sata M; Yamada K
    Exp Ther Med; 2011 Nov; 2(6):1035-1040. PubMed ID: 22977616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effects of angiotensin II type 1 receptor blocker, irbesartan, on non-alcoholic steatohepatitis using FLS-ob/ob male mice.
    Kato J; Koda M; Kishina M; Tokunaga S; Matono T; Sugihara T; Ueki M; Murawaki Y
    Int J Mol Med; 2012 Jul; 30(1):107-13. PubMed ID: 22469867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
    Ding Y; Sun X; Chen Y; Deng Y; Qian K
    Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression.
    Abd El-Haleim EA; Bahgat AK; Saleh S
    World J Gastroenterol; 2016 Mar; 22(10):2931-48. PubMed ID: 26973390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Green tea polyphenol epigallocatechin-3-gallate ameliorates insulin resistance in non-alcoholic fatty liver disease mice.
    Gan L; Meng ZJ; Xiong RB; Guo JQ; Lu XC; Zheng ZW; Deng YP; Luo BD; Zou F; Li H
    Acta Pharmacol Sin; 2015 May; 36(5):597-605. PubMed ID: 25891086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigallocatechin gallate improves insulin resistance in HepG2 cells through alleviating inflammation and lipotoxicity.
    Zhang Q; Yuan H; Zhang C; Guan Y; Wu Y; Ling F; Niu Y; Li Y
    Diabetes Res Clin Pract; 2018 Aug; 142():363-373. PubMed ID: 29940201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of hepatic sterol regulatory element-binding protein-1c-mediated gene expression contributes to Salacia oblonga root-elicited improvement of fructose-induced fatty liver in rats.
    Liu L; Yang M; Lin X; Li Y; Liu C; Yang Y; Yamahara J; Wang J; Li Y
    J Ethnopharmacol; 2013 Dec; 150(3):1045-52. PubMed ID: 24157375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects.
    Rametta R; Mozzi E; Dongiovanni P; Motta BM; Milano M; Roviaro G; Fargion S; Valenti L
    Int J Obes (Lond); 2013 Jul; 37(7):986-92. PubMed ID: 23147115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osthol ameliorates fat milk-induced fatty liver in mice by regulation of hepatic sterol regulatory element-binding protein-1c/2-mediated target gene expression.
    Du R; Xue J; Wang HB; Zhang Y; Xie ML
    Eur J Pharmacol; 2011 Sep; 666(1-3):183-8. PubMed ID: 21620823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.